Richard Barry, Director at Sarepta Therapeutics, holds 714.67K shares in Cassava Sciences (Ticker: SAVA), holds 3.22M shares in Sarepta Therapeutics (Ticker: SRPT), holds 3.34M shares in MiMedx Group (Ticker: MDXG). Most recently, Richard Barry Bought ― shares of Cassava Sciences on Sep 23, 2025 for an estimated value of $16.35K.
What is the percentage of profitable transactions made by Richard Barry?
The percentage of profitable transactions made by Richard Barry is 82%.
What is the average return per transaction made by Richard Barry?
The average return per transaction made by Richard Barry is 37.30%.
What stocks does Richard Barry hold?
Richard Barry holds: SRPT, MDXG, SAVA stocks.
What was Richard Barry’s latest transaction?
Richard Barry latest transaction was an Informative Buy of $16.35K.
What was Richard Barry's most profitable transaction?
Richard Barry’s most profitable transaction was an Informative Buy of SRPT stock on March 16, 2016. The return on the trade was 108.50%.
What is Richard Barry's role in Sarepta Therapeutics?
Richard Barry's role in Sarepta Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.